Activation of Akt by lithium: Pro-survival pathways in aging

Mechanisms of Ageing and Development

Volumn 130, Issue 4, 2009, Pages 253-261

  Tajes, Marta ^a   Yeste Velasco, Marc ^a   Zhu, Xiongwei ^b   Chou, Steven P ^b   Smith, Mark A ^b   Pallàs, Mercè ^a   Camins, Antoni ^a   Casadesús, Gemma ^b  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Lithium chloride; Neurodegeneration; Neuroprotection; SAMP8

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SENESCENCE ACCELERATED MOUSE;

AGING; ANIMALS; APOPTOSIS; CELLS, CULTURED; ENZYME ACTIVATION; LITHIUM; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; TISSUE CULTURE TECHNIQUES;

MUS;

EID: 60549100472     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2008.12.006     Document Type: Article

References (42)

1. Aghdam S.Y., and Barger S.W. Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium. Curr. Alzheimer Res. 4 (2007) 21-31
2. Alvarez G., Muñoz-Montaño J.R., Satrústegui J., Avila J., Bogónez E., and Díaz-Nido J. Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease. Bipolar Disord. 4 (2002) 153-165
3. Alvira D., Yeste-Velasco M., Folch J., Verdaguer E., Canudas A.M., Pallàs M., and Camins A. Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 147 (2007) 746-756
4. Caccamo A., Oddo S., Tran L.X., and LaFerla F.M. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am. J. Pathol. 170 (2007) 1669-1675
5. Canudas A.M., Gutierrez-Cuesta J., Rodríguez M.I., Acuña-Castroviejo D., Sureda F.X., Camins A., and Pallàs M. Hyper-phosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mech. Ageing Dev. 126 (2005) 1300-1304
6. Casadesus G., Smith M.A., Basu S., Hua J., Capobianco D.E., Siedlak S.L., Zhu X., and Perry G. Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease. Mol Neurodegener 2 (2007) 2
7. Chalecka-Franaszek E., and Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 8745-8750
8. Clancy D.J., Gems D., Harshman L.G., Oldham S., Stocker H., Hafen E., Leevers S.J., and Partridge L. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292 (2001) 104-106
9. Engel T., Hernández F., Avila J., and Lucas J.J. Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J. Neurosci. 26 (2006) 5083-5090
10. Essers M.A., de Vries-Smits L.M., Barker N., Polderman P.E., Burgering B.M., and Korswagen H.C. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308 (2005) 1181-1184
11. Fornai F., Longone P., Cafaro L., Kastsiuchenka O., Ferrucci M., Manca M.L., Lazzeri G., Spalloni A., Bellio N., Lenzi P., Modugno N., Siciliano G., Isidoro C., Murri L., Ruggieri S., and Paparelli A. Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 2052-2057
12. Giannakou M.E., Goss M., Jünger M.A., Hafen E., Leevers S.J., and Partridge L. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305 (2004) 361
13. Gutierrez-Cuesta J., Sureda F.X., Romeu M., Canudas A.M., Caballero B., Coto-Montes A., Camins A., and Pallàs M. Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8. J. Pineal. Res. 42 (2007) 394-402
14. Holzenberger M., Dupont J., Ducos B., Leneuve P., Géloën A., Even P.C., Cervera P., and Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421 (2003) 182-187
15. Holzenberger M., Lapointe F., and Ayer-LeLièvre C. Expression of insulin-like growth factor-I (IGF-I) and IGF-II in the avian brain: relationship of in situ hybridization patterns with IGF type 1 receptor expression. Int. J. Dev. Neurosci. 18 (2000) 69-82
16. Hwangbo D.S., Gershman B., Tu M.P., Palmer M., and Tatar M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 429 (2004) 562-566
17. Jordà E.G., Verdaguer E., Canudas A.M., Jiménez A., Garcia de Arriba S., Allgaier C., Pallàs M., and Camins A. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium. Neuroscience 134 (2005) 1001-1011
18. Manji H.K., Moore G.J., and Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?. Biol. Psychiatry 46 (1999) 929-940
19. Mason R.P., Leeds P.R., Jacob R.F., Hough C.J., Zhang K.G., Mason P.E., and Chuang D.M. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J. Neurochem. 72 (1999) 1448-1456
20. McColl G., Killilea D.W., Hubbard A.E., Vantipalli M.C., Melov S., and Lithgow G.J. Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans. J. Biol. Chem. 283 (2008) 350-357
21. +. Eur. J. Biochem. 266 (1999) 886-891
22. Mora A., Sabio G., Risco A.M., Cuenda A., Alonso J.C., Soler G., and Centeno F. Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell Signal. 14 (2002) 557-562
23. Pallàs M., Pizarro J.G., Gutierrez-Cuesta J., Crespo-Biel N., Alvira D., Tajes M., Yeste-Velasco M., Folch J., Canudas A.M., Sureda F.X., Ferrer I., and Camins A. Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 154 (2008) 1388-1397
24. Pallàs M., Camins A., Smith M.A., Perry G., Lee H.G., and Casadesus G. From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 15 (2008) 615-624
25. Pelegrí C., Canudas A.M., del Valle J., Casadesus G., Smith M.A., Camins A., Pallàs M., and Vilaplana J. Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Mech. Ageing Dev. 128 (2007) 522-528
26. Perry G., Roder H., Nunomura A., Takeda A., Friedlich A.L., Zhu X., Raina A.K., Holbrook N., Siedlak S.L., Harris P.L., and Smith M.A. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10 11 (1999) 2411-2415
27. Shao L., Young L.T., and Wang J.F. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol. Psychiatry 58 (2005) 879-884
28. Shao L., Cui J., Young L.T., and Wang J.F. The effect of mood stabilizer lithium on expression and activity of glutathiones-transferase isoenzymes. Neuroscience 151 (2008) 518-524
29. Sureda F.X., Gutierrez-Cuesta J., Romeu M., Mulero M., Canudas A.M., Camins A., Mallol J., and Pallàs M. Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8. Exp Gerontol 41 (2006) 360-367
30. Sugden P.H., Fuller S.J., Weiss S.C., and Clerk A. Glycogen synthase kinase3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 153 Suppl 1 (2008) S137-S153
31. Tajes M., Gutierrez-Cuesta J., Folch J., Ferrer I., Caballero B., Smith M.A., Casadesus G., Camins A., and Pallás M. Lithium treatment decreases activities of tau kinases in a murine model of senescence. J. Neuropathol. Exp. Neurol. 67 (2008) 612-623
32. Tatar M., Kopelman A., Epstein D., Tu M.P., Yin C.M., and Garofalo R.S. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292 (2001) 107-110
33. Takashima A. GSK-3β is essential in the pathogenesis of Alzheimer's disease. J. Alzheimer's Dis. 9 3 (2006) 309-317
34. Terao T., Nakano H., Inoue Y., Okamoto T., Nakamura J., and Iwata N. Lithium and dementia: a preliminary study. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1125-1128
35. 2+ homeostasis. Neuroreport 11 (2000) 3725-3729
36. Wada A., Yokoo H., Yanagita T., and Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J. Pharmacol. Sci. 99 (2005) 307-321
37. Wei H., Qin Z.H., Senatorov V.V., Wei W., Wang Y., Qian Y., and Chuang D.M. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience 106 3 (2001) 603-612
38. Yeste-Velasco M., Folch J., Trullàs R., Abad M.A., Enguita M., Pallàs M., and Camins A. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells. Neuropharmacology 53 (2007) 295-307
39. Yu I.T., Kim J.S., Lee S.H., Lee Y.S., and Son H. Chronic lithium enhances hippocampal long-term potentiation, but not neurogenesis, in the aged rat dentate gyrus. Biochem. Biophys. Res. Commun. 303 (2003) 1193-1198
40. Zhu X., Lee H.G., Raina A.K., Perry G., and Smith M.A. The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11 5 (2002) 270-281
41. Zhu X., Raina A.K., Rottkamp C.A., Aliev G., Perry G., Boux H., and Smith M.A. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76 2 (2001) 435-441
42. Zhu X., Rottkamp C.A., Boux H., Takeda A., Perry G., and Smith M.A. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59 10 (2000) 880-888